logo-loader
AIM:SAR

Sareum Holdings PLC

Receive alerts
Market:
AIM
Price
18.89 GBX
Day Change
2.11%
Market Cap:
£13.27 m
52 weeks high
149.00
52 weeks low
16.50

In brief

Sareum is a drug discovery and development company, headquartered in Cambridge UK, that produces targeted small molecule therapeutics, focusing on cancer and autoimmune disease. Sareum aims to successfully deliver drug candidates for licensing to pharmaceutical and biotechnology companies at the pre-clinical or early clinical trials stage.

Sareum operates an outsourced research model, working with collaborators (SRI International, the CRT Pioneer Fund and Hebei Medical University Biomedical Engineering Center) and a world-wide network of research providers. Its research pipeline includes two programmes undergoing pre-clinical IND-enabling studies.